Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Docosahexaenoic Acid (DHA) Supplementation During Pregnancy to Prevent Deep Placentation Disorders: A Randomized Clinical Trial and a Study of the Molecular Pathways of Abnormal Placentation Prevention

NCT02336243 is registered in ClinicalTrials.gov with Pontificia Universidad Catolica de Chile as lead sponsor.

NCT NCT02336243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02336243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Docosahexaenoic Acid (DHA) Supplementation During Pregnancy to Prevent Deep Placentation Disorders: A Randomized Clinical Trial and a Study of the Molecular Pathways of Abnormal Placentation Prevention
Lead sponsor
Pontificia Universidad Catolica de Chile
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2015
Completion date
April 30, 2018
Enrollment
2,400 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

fetal growth retardation, preeclampsia, premature birth, stillbirth